Trial Profile
Clinical Trials Insight: 700023284
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 18 May 2007
Price :
$35
*
At a glance
- Drugs VGX 150 (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- Sponsors VGX Pharmaceuticals
- 18 May 2007 New trial record.